Accuray (ARAY) – FDA
-
Accuray (ARAY) Says New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife System
-
Accuray (ARAY) Announces Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ARAY Stock Lookup